PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 52 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,891 | -26.2% | 7,408 | +7.5% | 0.00% | – |
| Q2 2023 | $31,015 | +455.2% | 6,892 | +603.3% | 0.00% | – |
| Q1 2023 | $5,586 | -10.8% | 980 | -5.5% | 0.00% | – |
| Q4 2022 | $6,263 | – | 1,037 | +1425.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 68 | -97.5% | 0.00% | – |
| Q2 2022 | $14,000 | +1300.0% | 2,706 | +1378.7% | 0.00% | – |
| Q1 2022 | $1,000 | -95.7% | 183 | -90.6% | 0.00% | – |
| Q4 2021 | $23,000 | -98.0% | 1,938 | -94.8% | 0.00% | – |
| Q3 2021 | $1,157,000 | +435.6% | 37,001 | +388.9% | 0.00% | – |
| Q2 2021 | $216,000 | -77.7% | 7,568 | -66.1% | 0.00% | – |
| Q1 2021 | $968,000 | +423.2% | 22,336 | +765.4% | 0.00% | – |
| Q4 2020 | $185,000 | +330.2% | 2,581 | +81.4% | 0.00% | – |
| Q3 2020 | $43,000 | – | 1,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |